Whistleblower: Johnson & Johnson Scientist Admits COVID Shot Was Unsafe
“People wanted it, we gave it to them,” says J&J scientist caught on hidden camera
In recently released footage from O’Keefe Media Group, Joshua Rys, a lead scientist at Johnson & Johnson, admits the company’s COVID-19 injection was brought to market despite a lack of research and serious safety concerns.
In the undercover video, Rys says the shot was rushed because there was public demand—not because it was proven safe or effective. The footage confirms what independent scientists and vaccine-injured Canadians have been saying for years: this product was not ready, and it was not safe.
When approached by journalist James O’Keefe for comment, Rys abruptly left the scene.
Key Points:
-
Rys states the J&J shot was released with insufficient safety research.
-
He admits the product was fast-tracked due to demand, not sound science.
-
J&J’s own Phase III trial data (Table S3) show:
-
75.7% of high-dose recipients reported adverse events (AEs)
-
18.2% experienced severe systemic reactions such as fever, malaise, and pain
-
Cardiovascular issues, including hypertension and bradycardia, were observed in older adults—some unresolved by the end of the trial
-
The trial did not assess long-term immunity. The need for repeated boosters and the occurrence of breakthrough infections directly contradicted initial claims of “95% efficacy.” As more data emerged, concerns grew around blood clots, neurological effects, and heart-related complications.
BREAKING: Johnson & Johnson Lead Scientist Confesses J&J COVID-19 Vaccine Was ‘Not Safe and Effective,’ Reveals “Lack of Research” From Rushing to Release Vaccine: “People Wanted It, We Gave It to Them”
“Do you have any idea the lack of research that was done on those products… pic.twitter.com/yEeyXy8toI
— James O’Keefe (@JamesOKeefeIII) July 15, 2025
Blood Clots and the TTS Connection
By March 2021, at least 60 cases of thrombosis with thrombocytopenia syndrome (TTS) were reported in the U.S. following the J&J injection. Nine individuals died. Yet health officials continued to promote the shot, calling the risks “rare” and acceptable.
Instead of pulling back, governments—including Canadian provincial and federal authorities—intensified efforts to boost uptake through mandates, coercion and discrimination. This shift undermined informed consent and medical ethics.
A Pattern of Regulatory Failure
The J&J case fits a broader pattern in pharmaceutical history—emergencies are exploited, risks are concealed and the public pays the price. Past examples include:
-
The Salk polio vaccine (which caused paralysis and death in some recipients)
-
The Merck Vioxx scandal (an arthritis drug later linked to an estimated 60,000 deaths)
- And of course J&J’s Baby Powder (40K+ lawsuits over it containing cancer-causing talc)
In every case, health agencies and media outlets failed to ask hard questions until it was too late. Today, the silence around vaccine injury remains widespread.
Time for Accountability
This footage, while disturbing, should not be ignored. It underscores the need for:
-
Full public access to clinical trial data
-
Independent safety reviews
-
Support for those who were harmed
-
Real consequences for corporate negligence
The vaccine rollout was not just a medical error—it was a systemic failure. Those responsible must be held to account.
Based on reporting by Lance D. Johnson (NewsTarget), July 20, 2025
Video footage: O’Keefe Media Group
Trial data: NEJM, MedRxiv
***************************************************************************************************************